In vitro studies on space-conforming self-assembling silk hydrogels as a mesenchymal stem cell-support matrix suitable for minimally invasive brain application
Osama, I. and Gorenkova, N. and McKittrick, C.M. and Wongpinyochit, T. and Goudie, A. and Seib, F.P. and Carswell, H.V.O. (2018) In vitro studies on space-conforming self-assembling silk hydrogels as a mesenchymal stem cell-support matrix suitable for minimally invasive brain application. Scientific Reports, 8. 13655. ISSN 2045-2322 (https://doi.org/10.1038/s41598-018-31905-5)
Preview |
Text.
Filename: Osama_etal_SR_2018_In_vitro_studies_on_space_conforming_self_assembling_silk_hydrogels.pdf
Final Published Version License: Download (2MB)| Preview |
Abstract
Advanced cell therapies require robust delivery materials and silk is a promising contender with a long clinical track record. Our aim was to optimise self-assembling silk hydrogels as a mesenchymal stem cell (MSC)-support matrix that would allow future minimally invasive brain application. We used sonication energy to programme the transition of silk (1-5% w/v) secondary structure from a random coil to a stable β-sheet configuration. This allowed fine tuning of self-assembling silk hydrogels to achieve space conformity in the absence of any silk hydrogel swelling and to support uniform cell distribution as well as cell viability. Embedded cells underwent significant proliferation over 14 days in vitro, with the best proliferation achieved with 2% w/v hydrogels. Embedded MSCs showed significantly better viability in vitro after injection through a 30G needle when the gels were in the pre-gelled versus post-gelled state. Silk hydrogels (4% w/v) with physical characteristics matching brain tissue were visualised in preliminary in vivo experiments to exhibit good space conformity in an ischemic cavity (intraluminal thread middle cerebral artery occlusion model ) in adult male Sprague-Dawley rats (n=3). This study informs on optimal MSC-hydrogel matrix conditions for minimally invasive application as a platform for future experiments targeting brain repair.
ORCID iDs
Osama, I. ORCID: https://orcid.org/0000-0002-2775-5417, Gorenkova, N. ORCID: https://orcid.org/0000-0002-6319-6640, McKittrick, C.M. ORCID: https://orcid.org/0000-0002-6374-2728, Wongpinyochit, T. ORCID: https://orcid.org/0000-0003-1339-6908, Goudie, A., Seib, F.P. ORCID: https://orcid.org/0000-0002-1955-1975 and Carswell, H.V.O. ORCID: https://orcid.org/0000-0002-0938-1212;-
-
Item type: Article ID code: 65289 Dates: DateEvent12 September 2018Published23 August 2018AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Technology and Innovation Centre > Bionanotechnology
Strategic Research Themes > Health and WellbeingDepositing user: Pure Administrator Date deposited: 28 Aug 2018 08:42 Last modified: 11 Nov 2024 12:05 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/65289